• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Identifying and responding to policy-related barriers, facilitators, and misunderstandings in the HEALing communities study: A community-driven approach.在“健康社区”研究中识别并应对与政策相关的障碍、促进因素和误解:一种社区驱动的方法。
Int J Drug Policy. 2025 Aug;142:104851. doi: 10.1016/j.drugpo.2025.104851. Epub 2025 May 22.
2
Protocol for community-driven selection of strategies to implement evidence-based practices to reduce opioid overdoses in the HEALing Communities Study: a trial to evaluate a community-engaged intervention in Kentucky, Massachusetts, New York and Ohio.HEALing 社区研究中实施基于证据的实践以减少阿片类药物过量的社区驱动策略选择方案:在肯塔基州、马萨诸塞州、纽约州和俄亥俄州评估一项社区参与式干预的试验。
BMJ Open. 2022 Sep 19;12(9):e059328. doi: 10.1136/bmjopen-2021-059328.
3
The HEALing (Helping to End Addiction Long-term ) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices.HEALing(帮助长期戒毒)社区研究:一项在社区层面进行的群组随机试验方案,通过实施一套综合的基于证据的实践来减少阿片类药物过量死亡。
Drug Alcohol Depend. 2020 Dec 1;217:108335. doi: 10.1016/j.drugalcdep.2020.108335. Epub 2020 Oct 17.
4
The Opioid-overdose Reduction Continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing Communities Study.阿片类药物过量减少关怀连续体方法(ORCCA):HEALing 社区研究中的循证实践。
Drug Alcohol Depend. 2020 Dec 1;217:108325. doi: 10.1016/j.drugalcdep.2020.108325. Epub 2020 Oct 4.
5
Health Services Usage in Patients Receiving Buprenorphine for Opioid Use Disorder or Long-Term Opioid Therapy for Chronic Pain: Retrospective Cohort Study.接受丁丙诺啡治疗阿片类物质使用障碍或长期阿片类药物治疗慢性疼痛患者的医疗服务利用情况:回顾性队列研究
JMIR Form Res. 2025 Jun 19;9:e66596. doi: 10.2196/66596.
6
System dynamics modeling to inform implementation of evidence-based prevention of opioid overdose and fatality: A state-level model from the New York HEALing Communities Study.用于指导实施基于证据的阿片类药物过量使用和死亡预防的系统动力学建模:来自纽约治愈社区研究的州级模型。
Int J Drug Policy. 2025 Aug;142:104843. doi: 10.1016/j.drugpo.2025.104843. Epub 2025 May 27.
7
Community selected strategies to reduce opioid-related overdose deaths in the HEALing (Helping to End Addiction Long-term ) communities study.社区选择的策略,以减少 HEALing(帮助长期戒除毒瘾)社区研究中与阿片类药物相关的过量死亡。
Drug Alcohol Depend. 2023 Apr 1;245:109804. doi: 10.1016/j.drugalcdep.2023.109804. Epub 2023 Feb 10.
8
Sentiment Analysis Using a Large Language Model-Based Approach to Detect Opioids Mixed With Other Substances Via Social Media: Method Development and Validation.使用基于大语言模型的方法通过社交媒体检测与其他物质混合的阿片类药物的情感分析:方法开发与验证
JMIR Infodemiology. 2025 Jun 19;5:e70525. doi: 10.2196/70525.
9
Communities That HEAL Intervention and Mortality Including Polysubstance Overdose Deaths: A Randomized Clinical Trial.社区康复干预与死亡率:包括多药物过量死亡的随机临床试验。
JAMA Netw Open. 2024 Oct 1;7(10):e2440006. doi: 10.1001/jamanetworkopen.2024.40006.
10
Transforming Opioid Overdose Prevention in the United States: Leveraging FDA's Narcan Approval to Foster a Culture of Health.转变美国阿片类药物过量预防:利用美国食品药品监督管理局对纳洛酮的批准来培育健康文化。
Risk Manag Healthc Policy. 2025 Jun 14;18:1935-1946. doi: 10.2147/RMHP.S521720. eCollection 2025.

本文引用的文献

1
Community coalitions' navigation of policies to address the opioid epidemic: insights from qualitative interviews in four states.社区联盟应对阿片类药物流行政策的实施:来自四个州定性访谈的见解
BMJ Public Health. 2025 Feb 27;3(1):e001924. doi: 10.1136/bmjph-2024-001924. eCollection 2025 Jan.
2
Evolution of an epidemic: Understanding the opioid epidemic in the United States and the impact of the COVID-19 pandemic on opioid-related mortality.疫情演变:了解美国的阿片类药物流行情况以及 COVID-19 大流行对阿片类药物相关死亡率的影响。
PLoS One. 2024 Jul 9;19(7):e0306395. doi: 10.1371/journal.pone.0306395. eCollection 2024.
3
Advocacy for patients with opioid use disorder: A primer for physicians and other clinicians on the Americans with Disabilities Act.为阿片类药物使用障碍患者发声:医生及其他临床医生关于《美国残疾人法案》的入门指南
J Opioid Manag. 2023 Special-Issue;19(7):53-60. doi: 10.5055/jom.2023.0799.
4
Four very basic ways to think about policy in implementation science.在实施科学中思考政策的四种非常基本的方式。
Implement Sci Commun. 2023 Sep 12;4(1):111. doi: 10.1186/s43058-023-00497-1.
5
State alignment with federal regulations in 2022 to relax buprenorphine 30-patient waiver requirements.2022年,该州与联邦法规保持一致,放宽了丁丙诺啡30名患者豁免要求。
Drug Alcohol Depend Rep. 2023 May 2;7:100164. doi: 10.1016/j.dadr.2023.100164. eCollection 2023 Jun.
6
Barriers and facilitators to the use of medication for opioid use disorder within the criminal justice system: Perspectives from clinicians.在刑事司法系统中使用药物治疗阿片类药物使用障碍的障碍和促进因素:临床医生的观点。
J Subst Use Addict Treat. 2023 Jun;149:209051. doi: 10.1016/j.josat.2023.209051. Epub 2023 Apr 19.
7
Budget impact tool for the incorporation of medications for opioid use disorder into jail/prison facilities.纳入监狱/看守所的阿片类药物使用障碍治疗药物的预算影响工具。
J Subst Use Addict Treat. 2023 Mar;146:208943. doi: 10.1016/j.josat.2022.208943. Epub 2023 Jan 26.
8
Community selected strategies to reduce opioid-related overdose deaths in the HEALing (Helping to End Addiction Long-term ) communities study.社区选择的策略,以减少 HEALing(帮助长期戒除毒瘾)社区研究中与阿片类药物相关的过量死亡。
Drug Alcohol Depend. 2023 Apr 1;245:109804. doi: 10.1016/j.drugalcdep.2023.109804. Epub 2023 Feb 10.
9
The policy landscape for naloxone distribution in four states highly impacted by fatal opioid overdoses.在四个受致命阿片类药物过量使用影响严重的州,纳洛酮分发的政策环境。
Drug Alcohol Depend Rep. 2023 Mar;6. doi: 10.1016/j.dadr.2022.100126. Epub 2022 Dec 5.
10
Where is "policy" in dissemination and implementation science? Recommendations to advance theories, models, and frameworks: EPIS as a case example.传播和实施科学中的“政策”在哪里?推进理论、模型和框架的建议:以 EPIS 为例。
Implement Sci. 2022 Dec 12;17(1):80. doi: 10.1186/s13012-022-01256-x.

在“健康社区”研究中识别并应对与政策相关的障碍、促进因素和误解:一种社区驱动的方法。

Identifying and responding to policy-related barriers, facilitators, and misunderstandings in the HEALing communities study: A community-driven approach.

作者信息

Silwal Anita, Bohler Robert, Hunt Timothy, Olvera Ramona G, Lofwall Michelle R, Cook Christopher D, Marks Katherine R, Bridden Carly, Freeman Patricia R, Nouvong Monica, Fanucchi Laura C, El-Bassel Nabila, Frazier Lisa A, Walsh Sharon L, Talbert Jeffery C

机构信息

School of Community Health Sciences, Counseling, and Counseling Psychology, Oklahoma State University, 441 Willard Hall, Stillwater, OK 74078, United States; Substance Use Priority Research Area (SUPRA), University of Kentucky, Lexington, KY, United States.

Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, GA, United States; Heller School for Social Policy and Management, Brandeis University, Waltham, MA, United States.

出版信息

Int J Drug Policy. 2025 Aug;142:104851. doi: 10.1016/j.drugpo.2025.104851. Epub 2025 May 22.

DOI:10.1016/j.drugpo.2025.104851
PMID:40409135
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12173346/
Abstract

INTRODUCTION

The HEALing (Helping to End Addiction Long-Term®) Communities Study (HCS) aimed to reduce opioid-involved overdose deaths across four states (Kentucky, Massachusetts, New York, and Ohio) via community-engaged implementation of three evidence-based practices (EBPs): (1) opioid overdose education and naloxone distribution, (2) medication for opioid use disorder expansion/linkage/retention, and (3) safer opioid prescribing and dispensing practices. A policy workgroup (PWG) was convened and developed a procedure to identify and address policies potentially impacting EBP implementation.

METHODS

A five-step method was developed to identify, track, and respond to relevant policies at three of the research sites (Kentucky, Massachusetts, and New York) in collaboration with community partners and stakeholders. Policies possibly impacting EBPs were reported, reviewed, and documented, including any actions taken to address the policy issue. Policies were discussed with local, state, and federal level stakeholders in attempts to resolve barriers, clarify misunderstandings, and disseminate facilitators.

RESULTS

A total of 87 (Kentucky = 37; Massachusetts = 19; New York = 31) policies were identified and addressed; 42 were identified as barriers, 24 as facilitators, and 21 as misunderstandings. PWG efforts resolved over 73 % (n = 31) of policy barriers, clarified 90 % (n = 19) of policy misunderstandings, and disseminated 100 % (n = 24) of policy facilitators.

CONCLUSIONS

A community-driven approach in policy surveillance identified, addressed, and disseminated several different types of policy issues that could impact implementation of EBPs for opioid-involved overdose prevention. Many policy barriers persisted during the HCS study, which may have adversely affected study outcomes.

摘要

引言

长期治愈成瘾(HEALing[帮助终结长期成瘾®])社区研究(HCS)旨在通过社区参与实施三项循证实践(EBPs),减少四个州(肯塔基州、马萨诸塞州、纽约州和俄亥俄州)涉及阿片类药物的过量用药死亡:(1)阿片类药物过量用药教育及纳洛酮分发;(2)阿片类药物使用障碍治疗药物的扩大使用/联系/留存;(3)更安全的阿片类药物处方和配药实践。一个政策工作组(PWG)召开会议并制定了一个程序,以识别和解决可能影响循证实践实施的政策。

方法

与社区合作伙伴和利益相关者合作,开发了一种五步方法,以识别、跟踪和应对三个研究地点(肯塔基州、马萨诸塞州和纽约州)的相关政策。报告、审查并记录了可能影响循证实践的政策,包括为解决政策问题所采取的任何行动。与地方、州和联邦层面的利益相关者讨论了政策,试图消除障碍、澄清误解并传播促进因素。

结果

共识别并解决了87项政策(肯塔基州 = 37项;马萨诸塞州 = 19项;纽约州 = 31项);42项被确定为障碍,24项为促进因素,21项为误解。政策工作组的努力解决了超过73%(n = 31)的政策障碍,澄清了90%(n = 19)的政策误解,并传播了100%(n = 24)的政策促进因素。

结论

政策监测中采用的社区驱动方法识别、解决并传播了几种可能影响预防涉及阿片类药物过量用药的循证实践实施的不同类型政策问题。在长期治愈成瘾社区研究期间,许多政策障碍仍然存在,这可能对研究结果产生了不利影响。